Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy

Journal of Nuclear Medicine

Volumn 44, Issue 10, 2003, Pages 1561-1565

  Alonso, Omar ^a,c   Martínez, Miguel ^a   Delgado, Lucía ^a   De León, Ana ^a   De Boni, Daniela ^a,b   Lago, Graciela ^a   Garcés, Mariela ^a   Fontes, Flávia ^a   Espasandín, José ^b   Priario, Julio ^a  

^a UNIVERSITY OF URUGUAY   (Uruguay)

^b National Institute of Oncology   (Uruguay)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

99mTc MIBI; Lymph node metastases; Melanoma

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT CANCER; TREATMENT OUTCOME; ADULT; AGED; COMPARATIVE STUDY; FEMALE; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; SKIN NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0642310795     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomised tnal comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000;7:87-97.
2. Voit C, Schoengen A, Schwurzer-Voit M, et al. The role of ultrasound in detection and management of regional disease in melanoma patients. Semin Oncol. 2002;29:353-360.
3. Swetter SM, Carroll LA, Johnson DL, Segall GM. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol. 2002;9:646-653.
4. Cascinelli N, Belli F, Santinami M, et al Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469-474.
5. Dubois RW, Swetter SM, Atkins M, et al. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. Arch Dermatol. 2001;137:1217-1224.
6. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement J Clin Oncol. 2001;19: 2851-2855
7. 18FDG PET imaging versus sentinel node detection. Oncologist. 2002;1:271-278.
8. 18FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact. Melanoma Res. 2002;52: 479-490
9. 67Ga SPET. Eur J Nucl Med Mol Imaging. 2002;29:506-515
10. Ribuffo D, Cavalieri L, De Vita F, et al. Current role of immunoscintigraphy in malignant melanoma follow-up: a study of 114 patients. J Exp Clin Cancer Res 2001;20:11-15.
11. 99mTc-MIBI scintigraphy. Melanoma Res 1998;8:355-360
12. 99mTc-MIBI [in Spanish]. Alasbimn J [serial online]. 1998. Available at: http.//www.alasbimnjournal.cl/revistas/l/melanoma htm. Accessed July 10, 2003.
13. Statius Muller MG, Van Leeuwen PA, Van Diest PJ, et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. World J Surg 2002;26:1405-1411.
14. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 1995;274:1703-1705.
15. Cascinelli N, Morabito A, Santimani M, et al Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk a randomized trial - WHO Melanoma Programme. Lancet. 1998;351:793-796
16. Reintgen DS. Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma. Ann Surg Oncol. 2000;7:75-76.
17. Mariani G, Gipponi M, Moresco L, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med. 2002;43:811-827.
18. Wrone DA, Tanabe KK, Cosimi AB, et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol 2000;136:511-514
19. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy: a common event. Surgery 2001;130:439-142
20. Clary BM, Mann B, Brady MS, Lewis JJ, Coit DG. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol. 2001;8:328-337.
21. Soler C, Perrot JL, Thiffet O, et al. The role of technetium-99m sestamibi single photon emission tomography in the follow-up of malignant melanoma and the detection of lymph node metastases Eur J Nucl Med. 1997;24:1522-1525.
22. Lens MB, Daweb M. Newton-Bishop JA, Goodacre T Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg. 2002;89:1223-1227.
23. Caraco C, Chiofalo MG, Niro J, et al. Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples: results from 240 sentinel node biopsies. Tumori. 2002;88(suppl):S12-S13.
24. Shen P, Guenther JM, Wanek LA, Morton DL. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences? Ann Surg Oncol. 2000;7:114-119.
25. Vignale R, Brugnini S, Martínez M, Alonso O, Fleurquin F. Regional ganglionar metastasis 24 years after surgical resection of a malignant melanoma. Int J Dermatol. 1998;37:44-45.
26. Kasner DL, Spieth ME The day of contamination. J Nucl Med Technol. 2003; 31:21-24
27. 99mTc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses? J Nucl Med 2001;42:1614-1621.
28. Crippa F, Leutner M, Belli F et al. Which kind of lymph node metastases can FDG PET detect? A clinical study in melanoma J Nucl Med. 2000;41:1491-1494.